A Canadian study has concluded a novel dual-hormone artificial pancreas system improves glucose control in patients with type 1 diabetes.
Researchers from McGill University’s Faculty of Medicine compared the dual-hormone system with a rapid insulin-alone artificial pancreas. According to the findings the D-HAP increased the blood glucose time in range from 74% to 84%. The hormones used in the dual system are insulin and pramlintide which is a synthetic form of the hormone amylin. Pramlintide works to reduce post-meal blood glucose levels by inhibiting the action of the glucose-raising hormone glucagon. Pramlintide slowed down food absorption, therefore giving insulin more time to work. Patients using the combination of hormones experienced a significant improvement in the time spent within the target blood glucose range.
Dr Ahmad Haidar and his team proposed the dual-hormone approach to improve blood glucose control in diabetes. Read the full article here!
I’m a type 1 diabetic with diabetes knowledge in t1d and t2d, as well as nutrition and low-carb keto diet information, fitness and exercise programs to help keep you in optimal diabetes health. Take advantage of our diabetic health tools for a healthier lifestyle!
This website uses cookies.
